Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference

Akebia Therapeutics (NASDAQ: AKBA) said its CEO John P. Butler and CFO/Chief Business Officer Erik Ostrowski will participate in a Fireside Chat at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026 at 8:00 AM ET in Miami.

Rhea-AI Summary

Akebia Therapeutics (NASDAQ: AKBA) said its CEO John P. Butler and CFO/Chief Business Officer Erik Ostrowski will participate in a Fireside Chat at the Leerink Partners 2026 Global Healthcare Conference on March 9, 2026 at 8:00 AM ET in Miami.

A webcast will be available via the company’s Investors website following the conference. The conference runs March 8-11, 2026.

Argus Mar 3 session

-3.17% close to close Open Argus

Details

News Market Reaction – AKBA

On Mar 3, the day this news came out, AKBA closed 3.17% below the previous close.

Data tracked by StockTitan Argus for the Mar 3 session.

Market Context

This announcement centers on Akebia management’s participation in the Leerink Partners conference on...

Analysis

This announcement centers on Akebia management’s participation in the Leerink Partners conference on March 9, 2026, continuing a cadence of investor-facing events. Recent history featured strong 2025 revenue growth, higher cash balances, and progress across Vafseo and rare kidney disease programs, balanced against ongoing losses and Auryxia generic risk. Investors may watch for any updated commentary on commercial trends, trial timelines, financing needs, and how management frames the competitive kidney-disease landscape.

Key Figures

Conference fireside chat date: March 9, 2026 Fireside chat time: 8:00 AM ET Conference dates: March 8–11, 2026

Conference fireside chat date

March 9, 2026

Leerink Partners 2026 Global Healthcare Conference appearance

Fireside chat time

8:00 AM ET

Scheduled start time for management presentation

Conference dates

March 8–11, 2026

Leerink Partners 2026 Global Healthcare Conference duration

Historical Context

5 past events · Latest: Feb 26

5 events

1. Feb 26

   Quarterly earnings

   24h Move

   +9.1%

   Stronger 2025 revenues and cash with guidance for Vafseo growth.

2. Feb 19

   Earnings date set

   24h Move

   +0.0%

   Announcement of timing and access details for earnings call.

3. Feb 04

   Conference appearance

   24h Move

   -2.8%

   Management participation in Guggenheim biotech summit fireside chat.

4. Feb 02

   Inducement grants

   24h Move

   +2.2%

   Stock option inducement awards to new employees under Nasdaq rules.

5. Jan 12

   Pipeline update

   24h Move

   -7.9%

   Vafseo access growth and multiple mid‑ to late‑stage trial milestones.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics^®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in a Fireside Chat at the Leerink Partners 2026 Global Healthcare Conference on Monday, March 9 at 8:00 AM ET.

A webcast of the presentation can be accessed through the “Investors” section of Akebia’s website at https://ir.akebia.com following the conference.

The Leerink Partners 2026 Global Healthcare Conference will take place March 8-11, 2026, in Miami.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com  

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Akebia Therapeutics (AKBA) present at the Leerink Partners 2026 Global Healthcare Conference?

Akebia will present on March 9, 2026 at 8:00 AM ET in a Fireside Chat. According to Akebia, CEO John P. Butler and CFO Erik Ostrowski will participate and discuss company developments during the session.

Who from Akebia (AKBA) will participate in the company’s Leerink 2026 Fireside Chat?

John P. Butler, CEO, and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate. According to Akebia, both executives will appear together to discuss corporate and financial topics at the conference.

How can investors watch Akebia Therapeutics’ (AKBA) Leerink 2026 presentation?

A webcast will be available via Akebia’s Investors website after the conference. According to Akebia, the webcast can be accessed through the “Investors” section at the company’s IR website following the event.

What is the schedule for the Leerink Partners 2026 Global Healthcare Conference where Akebia (AKBA) will appear?

The conference runs March 8-11, 2026 in Miami, with Akebia scheduled for March 9. According to Akebia, the event features multiple sessions including the company’s Fireside Chat on March 9 at 8:00 AM ET.

Will Akebia Therapeutics (AKBA) share financial results during the Leerink 2026 Fireside Chat?

The announcement does not specify new financial results will be released during the Fireside Chat. According to Akebia, the session will feature CEO and CFO discussion; investors should monitor the webcast for any disclosed updates.

Where is the Leerink Partners 2026 Global Healthcare Conference being held for Akebia’s (AKBA) presentation?

The conference takes place in Miami, and Akebia’s Fireside Chat is scheduled for March 9, 2026. According to Akebia, the event occurs March 8-11 with the company’s presentation included in the program.